TY - JOUR T1 - Severe T2-high asthma in the biologics era: European experts' opinion JF - European Respiratory Review JO - EUROPEAN RESPIRATORY REVIEW DO - 10.1183/16000617.0054-2019 VL - 28 IS - 152 SP - 190054 AU - Ian Pavord AU - Thomas Bahmer AU - Fulvio Braido AU - Borja G. Cosío AU - Marc Humbert AU - Marco Idzko AU - Lukasz Adamek Y1 - 2019/06/30 UR - http://err.ersjournals.com/content/28/152/190054.abstract N2 - The European Respiratory Biologics Forum gathered participants from 21 countries in Madrid, Spain, to discuss the management and treatment of severe asthma in the era of biologics. The current insights on the pathophysiology of severe asthma were discussed, as well as the role of respiratory biologics in clinical practice and strategies for eliminating chronic use of oral corticosteroids. The participants also highlighted the key challenges in identifying patients with severe asthma based on phenotypes, biomarkers and treatable traits, and the existing problems in patient referral to specialist care. The monitoring of treatment was debated and the need for a change towards precision medicine and personalised care was emphasised throughout the meeting. This review provides a summary of the discussions and highlights important concerns identified by the participants regarding the current management of severe asthma.This review provides a summary of the discussions and highlights important concerns identified by the participants of the European Respiratory Biologics Forum on the current management of severe asthma. http://bit.ly/2YhpP1k ER -